M
IMEPro
E11.9 Internal Medicine
Updated March 2026

Type 2 diabetes mellitus without complications

ICD-10 Code: E11.9 · Body Part: Lumbar Spine

QME Evaluation Process

HbA1c, fasting glucose, end-organ screening. Relevant for apportionment when diabetes affects healing or contributes to neuropathy. Chapter 10 endocrine impairment.

Typical Impairment Rating

5-20% WPI based on control and end-organ damage

AMA Guides Edition

5th Edition

Common Treatments

+ Metformin
+ Insulin if needed
+ Dietary management
+ Exercise

Related Conditions

Body Part Guide

Lumbar Spine Evaluation Guide

Impairment rating methods, common conditions, and QME evaluation protocols

View Guide →

QME Specialties for Type 2 diabetes mellitus without complications

Find a QME Specialist

Browse QME-certified physicians who evaluate type 2 diabetes mellitus without complications and related lumbar spine conditions in California.

Browse Neurology Physicians →

Frequently Asked Questions

What is Type 2 diabetes mellitus without complications (E11.9)?

Type 2 diabetes mellitus without complications is an ICD-10 diagnosis code (E11.9) classified under Internal Medicine conditions. It affects the Lumbar Spine and is occasionally seen in California workers' compensation claims. QME physicians evaluate this condition using AMA Guides 5th Edition protocols.

How is E11.9 rated for impairment?

The typical whole person impairment (WPI) range for Type 2 diabetes mellitus without complications is 5-20% WPI based on control and end-organ damage. The exact rating depends on clinical findings, imaging, and the evaluation method (DRE or ROM) chosen by the QME physician per AMA Guides 5th Edition.

What is the QME evaluation process for E11.9?

HbA1c, fasting glucose, end-organ screening. Relevant for apportionment when diabetes affects healing or contributes to neuropathy. Chapter 10 endocrine impairment.

What treatments are common for Type 2 diabetes mellitus without complications?

Common treatments for Type 2 diabetes mellitus without complications include Metformin, Insulin if needed, Dietary management, Exercise. Treatment appropriateness and outcomes are considered during the QME evaluation when determining permanent and stationary status and apportionment.